Additionally, reduced first-phase insulin secretion was found to be the earliest and most detrimental defect in β cells in humans with impaired glucose tolerance (prediabetes) and type 2 diabetes [10,11]. The gene discussed is INS; the disease is type 2 diabetes mellitus.